{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:58:57Z","timestamp":1792648737640,"version":"4.5.0"},"reference-count":42,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Sports Med"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>An increase in matrix metalloproteinases (MMPs) and the resulting degradation of the extracellular matrix have been implicated in the pathogenesis of tendinopathy. Studies have documented the beneficial effects of MMP inhibitors used to treat pathologic conditions in which MMP activity has had a negative effect on connective tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Matrix metalloproteinase inhibitors will prevent the decrease in material properties associated with tendon stress deprivation by inhibiting MMP activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design<\/jats:title>\n                    <jats:p>Controlled laboratory study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Rat tail tendons were subjected to 7 days of in vitro stress deprivation with and without the addition of 1 of 2 broad-spectrum MMP inhibitors (doxycycline and ilomastat). The material properties (ultimate tensile stress, strain, and tensile modulus) of the tendons were compared with each other and with fresh control tendons. In addition, tendons from each group were evaluated for MMP-13 messenger RNA expression, MMP-13 protein synthesis, MMP-13 activity, and pericellular matrix morphology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Both MMP inhibitors resulted in a statistically significant reduction in MMP activity in 7 day stress-deprived tendons when compared with nontreated, stress-deprived tendons. Similarly, tendons treated with either ilomastat or doxycycline had significantly improved material properties. MMP-13 messenger RNA expression and protein synthesis were not significantly affected by either MMP inhibitor. Both MMP inhibitors were able to maintain the integrity of the pericellular matrix when compared with nontreated, stress-deprived tendons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Matrix metalloproteinase inhibitors prevented the activation of MMP-13 and significantly inhibited pericellular matrix degeneration and the loss of material properties associated with stress deprivation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Relevance<\/jats:title>\n                    <jats:p>Matrix metalloproteinase inhibitors may play a supportive role in the treatment of tendinopathy by limiting the MMP-mediated degradation of the extracellular matrix.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0363546506296043","type":"journal-article","created":{"date-parts":[[2007,2,9]],"date-time":"2007-02-09T20:54:42Z","timestamp":1171054482000},"page":"763-769","source":"Crossref","is-referenced-by-count":107,"title":["Matrix Metalloproteinase Inhibitors Prevent a Decrease in the Mechanical Properties of Stress-Deprived Tendons"],"prefix":"10.1177","volume":"35","author":[{"given":"Steven P.","family":"Arnoczky","sequence":"first","affiliation":[{"name":"Laboratory for Comparative Orthopaedic Research, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lavagnino","sequence":"additional","affiliation":[{"name":"Laboratory for Comparative Orthopaedic Research, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Egerbacher","sequence":"additional","affiliation":[{"name":"Laboratory for Comparative Orthopaedic Research, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Caballero","sequence":"additional","affiliation":[{"name":"Laboratory for Comparative Orthopaedic Research, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri","family":"Gardner","sequence":"additional","affiliation":[{"name":"Laboratory for Comparative Orthopaedic Research, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2007,5]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0625.2001.100506.x"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-0266(03)00107-4"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00007256-199520020-00003"},{"key":"e_1_3_1_5_2","first-page":"46","article-title":"The response of tendon cells to changing loads: implications in the etiopathogenesis of tendinopathy","author":"Arnoczky SP","year":"2007","unstructured":"ArnoczkySP, LavagninoM., EgerbacherM.The response of tendon cells to changing loads: implications in the etiopathogenesis of tendinopathy. In: Woo SL-Y, Renstrom P, Arnoczky SP, eds. Tendinopathy in the Athlete, IOC Encyclopedia ofSports Medicine. 2007:46\u201359.","journal-title":"Sports Medicine"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2004.65.491"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-0266(03)00185-2"},{"key":"e_1_3_1_8_2","first-page":"270","article-title":"Case reports of aprotinin in Achilles tendinopathy with athletes","volume":"16","author":"Aubin F.","year":"1997","unstructured":"AubinF., JavaudinL., RochcongarP.Case reports of aprotinin in Achilles tendinopathy with athletes. Journal de Pharmacie Clinique.1997;16:270\u2013273.","journal-title":"Journal de Pharmacie Clinique."},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb07737.x"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.blo.0000144166.66737.3a"},{"key":"e_1_3_1_11_2","first-page":"243","volume-title":"Synthetic inhibitors of matrix metalloproteinasesMatrix Metalloproteinases","author":"Brown PD","year":"1998","unstructured":"BrownPDSynthetic inhibitors of matrix metalloproteinases. In: ParksWC, MechamRP, eds. Matrix Metalloproteinases. San Diego, Calif: Academic Press; 1998:243\u2013262."},{"key":"e_1_3_1_12_2","first-page":"37","article-title":"Preliminary results with peritendinous protease inhibitor injections in the management of Achilles tendonitis","volume":"15","author":"Capasso G.","year":"1993","unstructured":"CapassoG., MaffulliN., TestaV., SgambatoA.Preliminary results with peritendinous protease inhibitor injections in the management of Achilles tendonitis. J Sports Traumatol Rel Res. 1993;15:37\u201343.","journal-title":"J Sports Traumatol Rel Res"},{"key":"e_1_3_1_13_2","first-page":"111","article-title":"Aprotinin, corticosteroids and normosaline in the management of patellar tendinopathy in athletes: a prospective randomized study","volume":"3","author":"Capasso G.","year":"1997","unstructured":"CapassoG., TestaV., MaffulliN., BifulcoG.Aprotinin, corticosteroids and normosaline in the management of patellar tendinopathy in athletes: a prospective randomized study. Sports Exercise and Injury.1997;3:111\u2013115.","journal-title":"Sports Exercise and Injury."},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-0266(02)00016-5"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.54.7.571"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-0412"},{"key":"e_1_3_1_17_2","first-page":"1100","article-title":"Stress-deprivation of tendons results in alterations in the integrin profile and peri-cellular matrix of tendon cells","volume":"31","author":"Egerbacher M.","year":"2006","unstructured":"EgerbacherM., ArnoczkySP, GardnerK., CaballeroO., GartnerJ.Stress-deprivation of tendons results in alterations in the integrin profile and peri-cellular matrix of tendon cells. Trans Orthop Res Soc.2006;31:1100.","journal-title":"Trans Orthop Res Soc."},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/17453670209178031"},{"key":"e_1_3_1_19_2","first-page":"54","article-title":"Doxycycline concentration levels in bone, soft tissue, and serum after intravenous infusion of doxycycline","volume":"9","author":"Gnarpe H.","year":"1976","unstructured":"GnarpeH., DornbuschK., HaggO.Doxycycline concentration levels in bone, soft tissue, and serum after intravenous infusion of doxycycline. Scand J Infect Dis.1976;9(suppl):54\u201357.","journal-title":"Scand J Infect Dis."},{"key":"e_1_3_1_20_2","first-page":"297","article-title":"Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral","volume":"2","author":"Golub LM","year":"1991","unstructured":"GolubLM, GreenwaldRA, RamamurthyNS, McNamaraTF, RifkinBRTetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev OralBiol Med.1991;2: 297\u2013321.","journal-title":"Biol Med."},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007632-199807150-00021"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00146a017"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/08959374980120010301"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1999.0755"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0945-053X(01)00128-7"},{"key":"e_1_3_1_26_2","first-page":"15","volume-title":"Interstitial collagenasesMatrix Metalloproteinases","author":"Jeffrey JJ","year":"1998","unstructured":"JeffreyJJInterstitial collagenases. In: ParksWC, MechamRP, eds. Matrix Metalloproteinases. San Diego, Calif: Academic Press; 1998: 15\u201342."},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21672"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.orthres.2005.04.001"},{"key":"e_1_3_1_29_2","first-page":"329","article-title":"In vitro stress-deprivation alters the mechanostat set point of tendon cells","volume":"31","author":"Lavagnino M.","year":"2006","unstructured":"LavagninoM., ArnoczkySP, CaballeroO., RobertsonEM, NashiSMIn vitro stress-deprivation alters the mechanostat set point of tendon cells. Trans Orthop Res Soc.2006;31:329.","journal-title":"Trans Orthop Res Soc."},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiomech.2005.08.008"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiomech.2004.03.035"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/03008200390215881"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/0363546503262200"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2005.017855"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-012545090-4\/50012-4"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0945-053X(01)00196-2"},{"key":"e_1_3_1_37_2","first-page":"85","article-title":"Matrix metalloproteinases and their inhibition in periodontal treatment","volume":"3","author":"Ryan ME","year":"1996","unstructured":"RyanME, RamamurthyNS, GolubLMMatrix metalloproteinases and their inhibition in periodontal treatment. Curr Opin Peridontol.1996;3: 85\u201396.","journal-title":"Curr Opin Peridontol."},{"key":"e_1_3_1_38_2","first-page":"187","article-title":"Tendon injury and tendinopathy: healing and repair","volume":"87","author":"Sharma P.","year":"2005","unstructured":"SharmaP., MaffulliN.Tendon injury and tendinopathy: healing and repair. J Bone Joint Surg Am. 2005;87:187\u2013202.","journal-title":"J Bone Joint Surg Am"},{"key":"e_1_3_1_39_2","first-page":"835","article-title":"Regulation of cartilage collagenase by doxycycline","volume":"28","author":"Shlopov BV","year":"2001","unstructured":"ShlopovBV, StuartJM, GumanovskayaML, HastyKARegulation of cartilage collagenase by doxycycline. J Rheumatol.2001;28:835\u2013842.","journal-title":"J Rheumatol."},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1994.tb24778.x"},{"key":"e_1_3_1_41_2","first-page":"532","article-title":"Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage","volume":"25","author":"Smith GN","year":"1998","unstructured":"SmithGN Jr, YuLP Jr, BrandtKD, CapelloWNOral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage. J Rheumatol.1998;25:532\u2013535.","journal-title":"J Rheumatol."},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780351007"},{"key":"e_1_3_1_43_2","first-page":"1324","article-title":"Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis","volume":"24","author":"Zernicke RF","year":"1997","unstructured":"ZernickeRF, WohlGR, GreenwaldRA, MoakSA, LengW., GolubLMAdministration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis. J Rheumatol.1997;24: 1324\u20131331.","journal-title":"J Rheumatol."}],"container-title":["The American Journal of Sports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0363546506296043","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0363546506296043","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0363546506296043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:41:38Z","timestamp":1777369298000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0363546506296043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1177\/0363546506296043"],"URL":"https:\/\/doi.org\/10.1177\/0363546506296043","relation":{},"ISSN":["0363-5465","1552-3365"],"issn-type":[{"value":"0363-5465","type":"print"},{"value":"1552-3365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}